Contact Uscontact

Parc Euromédecine, Cap Gamma
1682 Rue de la Valsière - CS17383
34189 Montpellier cedex 4 - FRANCE

Office +33 (0)4 67 727 670
FAX : +33 (0)4 67 727 679

Out-LicensingOut-Licensing 

3 oncology-focused projects, including novel targeted therapies (molecules and antibodies), under development and potentially available for licensing or collaboration.
» Read more ...

Newsrss

04/25/13 : OriBase Pharma is entitled to taxes return for investment

Thanks to a first round of fund raising realized successfully ( 1 500 000€), involving 52 investors, we were able...
» Read more ...

Investor Relations

Looking for value?

OriBase Pharma is transforming the challenges of drug development into opportunities to create innovative therapies with significant clinical and commercial potential.

OriBase Pharma as an investment case

investorRelations

OriBase Pharma is an innovative European R&D-based pharmaceutical company with a special emphasis on developing medicinal treatments for aggressive  cancers. OriBase Pharma discovers and develops active anticancer drug candidates up to phase II. OriBase Pharma’s customers are mainly pharmaceutical companies.

The objective of OriBase Pharma’s intensive research is to bring new innovative patented proprietary drugs to pharmaceutical companies for international markets. OriBase Pharma’s pharmaceutical R&D focuses on oncology indications such as:

The present OriBase Pharma Corporation started operations on 13 September 2007.

Reasons to invest